PPH 股价走势图
PPH 股票价格预测
VanEck Pharmaceutical ETF
$100.83
-1.36%
$-1.4
收盘价：May 07, 16:00:00 GMT-4
$101.63
0.79%
$0.79
盘后：May 07, 20:00:00 GMT-4
返回
VanEck Pharmaceutical ETF (PPH) 股票价格预测
According to analyst forecasts, we anticipate notable price fluctuations for PPH in the upcoming periods. Looking toward the future, our 2026 projection indicates an average price target of $116.07. The lowest target is $91.06 and the highest is $143.89. Empower your investment choices with our cutting-edge, data-driven analysis!
PPH 股价预测摘要
我应该买PPH吗？
PPH的顶级分析师评级
基于 24 位分析师对 PPH 的股票评级，更新于 Oct 01, 2025
Strong buy
8
Buy
9
Hold
6
Sell
1
Strong sell
0
Leveraging in-depth analyst evaluations, we have synthesized key insights from expert assessments to present a positive outlook for PPH. Analysts highlight solid fundamentals and favorable market sentiment, suggesting upside potential in the near term. Based on this thorough expert analysis, we maintain an optimistic view of this stock. Our conclusion: PPH is a Buy candidate.
PPH stock price ended at $100.69 on 星期四, after dropping 1.51%
On the latest trading day May 07, 2026, the stock price of PPH fell by 1.51%, dropping from $101.68 to $100.69. During the session, the stock saw a volatility of 1.40%, with prices oscillating between a daily low of $100.39 and a high of $101.80. On the latest trading day, the trading volume for PPH rose by 2.4K shares, despite the declining prices. This uptick in volume may signal heightened risk in the near term. In total, 100.4K shares were traded, with a market value of approximately $936.8M.
PPH 技术面信号
技术面信号摘要
Strong Sell
Sell
Neutral
Buy
Strong Buy
PPH目前显示2个买入信号和3个卖出信号。该股票自12:00 AM以来一直处于下降趋势状态，在此期间价格总变动为-1.86%。总体而言，技术指标显示中期前景为Sell。
PPH 的看涨/看跌信号
我们的算法通过分析移动平均线、RSI、MACD 和成交量等关键指标，为 PPH 生成看涨和看跌信号。这些见解可助您做出明智的投资决策。
关键数据
前收盘价
$102.23
开盘价
$101.7
当日区间
$100.37 - $101.8
52周范围
$81.74 - $112.58
交易量
106.5K
平均成交量
375.3K
股息收益率
1.76%
净资产
$0
资产净值
--
费用率
--
已发行股份
9.3M
什么是 PPH？
PPH 由 VanEck 于 2011 年 12 月 20 日创建。该基金的投资组合主要集中在医疗保健类股票。该 ETF 目前管理资产达 5.5348 亿美元，拥有 24 只持仓证券。PPH 跟踪一只由全球规模最大的 25 家制药公司组成的市值加权指数。
